Axtria Thought Leadership

Executive insights and perspectives on the Life Sciences industry
Are Pharmaceutical Direct-To-Consumer TV Ads Appropriate? A Commentary

White Paper

Are Pharmaceutical Direct-To-Consumer TV Ads Appropriate? A Commentary

No pharmaceutical topic causes as much passionate difference of opinions between industry and medical community representatives as the practice of direct-to-consumer advertising (D ...

Regional Sales And Marketing Optimization Modeling: A Call For Technical Changes

White Paper

Regional Sales And Marketing Optimization Modeling: A Call For Technical Changes

The concept of “all marketing is local” in the pharma environment is more valid today than ever before. We see tremendous variations in salient factors that would affect commer ...

Traditional Call Planning

Blog

Quantifying The Economic Burden Of Inadequate Symptom Control Among Patients With IBS-D

Axtria recently collaborated on a study to analyze the “Economic burden of inadequate symptom control among US commercially insured patients with irritable bowel syndrome wit ...

Traditional Call Planning

Blog

Insightful HEOR Analysis For The Cardiovascular Community

Some of the most rewarding work we are involved in at Axtria right now is in the Health Economics and Outcomes Research (HEOR) space, where we are partnering with our clients to ...

AstraZeneca’s Bold And Potentially Risky New Cancer Drug R&D Portfolio Strategy

Blog

Quantifying The Economic Burden Of IBS-D

As the industry shifts from volume to value based models, it is becoming necessary for Pharmaceutical companies to demonstrate the value their brands deliver through outcomes and e ...

Decision Science Asset Diversification Versus Concentration

White Paper

Decision Science Asset Diversification Versus Concentration

The pharmaceutical industry continues to undergo tremendous changes. The questions for executives are how do these changes affect the direction of investments in new decision scien ...

Achieving Sales Operations Excellence With Intelligent Roster Management

White Paper

Achieving Sales Operations Excellence With Intelligent Roster Management

Effective roster management has long been an overlooked topic in Pharma commercial operations. At any point in time, it is critical for the Sales Operations business processes to h ...

The Reasons for and Solutions to Chronic Drug Shortages in the United States

White Paper

The Reasons for and Solutions to Chronic Drug Shortages in the United States

This white paper will briefly address the questions and present the key reasons for and solutions to the existence of chronic drug shortages in the US. It will also discuss the rol ...

Pricing and Market Effects of Biosimilar Entry in the US

White Paper

Pricing and Market Effects of Biosimilar Entry in the US

This white paper will provide insights into key questions as they pertain to the entry of biosimilars in the US market, pricing and market effects and the future of biosimilars in ...